What Researchers Did
The researchers searched medical databases for animal and human studies on hyperbaric oxygen therapy (HBOT) and nerve-related chronic pain, then summarized how it might work and how well it performed.
What They Found
This narrative review of 29 studies, selected from 2971 citations, reported that the evidence for HBOT was described as robust for chronic regional pain syndrome and chronic primary bladder pain syndrome. Some evidence supported its use for radiation-induced plexus neuropathies, postherpetic neuralgia, and trigeminal neuralgia. The review listed possible mechanisms, including hyperoxia, edema resolution, and reduced inflammatory mediators. Animal models showed antinociceptive and analgesic effects. Human studies reported improvements in pain scores, pain-related symptoms, and quality of life. The abstract also states that the role and efficacy of HBOT remain unclear.
What This Means for Canadian Patients
For people with chronic nerve-related pain, this review suggests HBOT has been studied in several pain conditions, with the strongest evidence reported for chronic regional pain syndrome and chronic primary bladder pain syndrome. The abstract says the evidence for the other conditions is only "some" and that a systematic way of applying HBOT is needed to confirm its safety and efficacy. It does not give treatment pressures or session numbers, so patients should talk with their own doctor about whether it fits their situation.
Canadian Relevance
The authors are affiliated with Canadian institutions, so the study has a Canadian connection.
Study Limitations
This is a narrative review rather than a pooled analysis, it only included English-language articles, and the abstract says a systematic methodology of HBOT application is still needed to confirm safety and efficacy.